Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation
about
In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donorsVirus-encoded superantigensFunctional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression.The role of EBV in post-transplant malignancies: a review.Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?Humanized mouse models of epstein-barr virus infection and associated diseases.Skipping the two-step? Possible mechanisms of Epstein-Barr virus reactivation.LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disordersGain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorderAn Epstein-Barr virus-associated superantigenCD4 T cell responses in latent and chronic viral infections.Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.Murine Models of Epstein-Barr Virus-Associated Lymphomagenesis.Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease.The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses.Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes.Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus.Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cellsLymphomas can develop from B cells chronically helped by idiotype-specific T cellsTumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation.Infection of simian B lymphoblastoid cells with simian immunodeficiency virus is associated with upregulation of CD23 and CD40 cell surface markers.
P2860
Q28362603-E964CAD3-815E-4801-AEFE-A0DEE0DDED3BQ28776748-B3D7A467-9EAF-49F9-A195-E6DCDBA31CB4Q33808262-B566C46C-D5AE-46CA-9197-CFD3092AF051Q33925488-A6C3CE55-E47C-4804-B91D-0BE8BB311E06Q34058148-C3547FBB-35B6-45EB-B6CE-A9351665637DQ34275895-C08E4079-E931-4975-A5D7-844C7B963C75Q34372087-10682F8B-7188-45D1-AC6B-75566F17CC3FQ34533579-CE7CA905-A482-4A4E-B28B-CD92851FCD46Q35186877-17A9FDA8-9A7D-4779-939E-D2C68A201585Q35242466-1CBFA0A0-FE32-4089-AFDF-4CD33B0C9F86Q35494359-8A230809-1F75-4321-B5D5-129FD2F5EA6AQ35795114-420351F2-35FD-45E5-886F-C2C5850D1AECQ35839280-14D90801-AC9D-4163-925B-A528E186773EQ36041314-6746D77A-2116-4A17-98EF-61DDF998163FQ36367270-7D3F3EF4-A6A3-43D8-94AB-0A186B7C9402Q36837631-19164957-41F0-424A-B11A-980AB209E072Q37667998-AFB763B9-1642-4049-9457-B21C14683C9CQ37773234-F7D0107D-ED1E-457C-BA61-4A0DABFC1EE3Q38795321-34AFBCE9-A946-469D-89FA-888E02BFB067Q39349824-CCDCF85A-BB8D-4B80-AE2C-54374469A847Q39545359-058B9F3A-8AAD-4BC4-B0AF-E27EDB45E07DQ39868327-6EBBA096-70C4-4A71-AE4F-FF4BF1143BFDQ40487893-BA9F5987-D8AE-4621-88EB-F7B229F958DAQ40572803-94EF5D5B-EF77-4328-AC01-154F111C05FAQ41982582-0F099895-2B81-4AC8-8661-C48770E80F19Q44529459-C8C3948D-251F-43E6-8C58-D447B0D57AA8Q45731070-33AA8F95-CB56-489F-840B-53FE5D866CA3
P2860
Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Lymphoproliferative disease in ...... nt for B cell tumor generation
@ast
Lymphoproliferative disease in ...... nt for B cell tumor generation
@en
type
label
Lymphoproliferative disease in ...... nt for B cell tumor generation
@ast
Lymphoproliferative disease in ...... nt for B cell tumor generation
@en
prefLabel
Lymphoproliferative disease in ...... nt for B cell tumor generation
@ast
Lymphoproliferative disease in ...... nt for B cell tumor generation
@en
P2093
P2860
P356
P1476
Lymphoproliferative disease in ...... nt for B cell tumor generation
@en
P2093
A Del Mistro
A Veronesi
E D'Andrea
M L Veronese
R Zamarchi
P2860
P304
P356
10.1084/JEM.176.6.1763
P407
P577
1992-12-01T00:00:00Z